Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00916240 · ClinicalTrials.gov registry record · NA
Multisystemic Therapy to Reduce Health Disparities in Adolescents With Asthma
A NA study, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- NA
- Development phase
- 170
- Enrollment target
NCT00916240 is a NA study that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 170 participants.
The verdict
NCT00916240, a NA study, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- NA
- Development phase
- 170 participants
- Enrollment target
Study Summary
Asthma is a chronic lung disease that inflames and narrows the airways. Symptoms can include recurring periods of wheezing, chest tightness, shortness of breath, and coughing. Minority, inner city teens are at increased risk for complications from the disease, possibly because of poor illness management. The purpose of this study is to test the effectiveness of Multisystemic Therapy (MST)-an intensive, home- and community-based psychotherapy-for improving asthma management and overall health and for reducing healthcare costs for inner city African American teens with asthma.
Interventions
- BEHAVIORAL Multisystemic Therapy
- BEHAVIORAL Home-based, Non-Directive Family Support
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2008-09 |
| Est. Completion | 2013-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00916240
The ClinicalTrials.gov registry entry for NCT00916240 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Multisystemic Therapy is the first listed.
NCT00916240 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00916240 about?
NCT00916240 is a clinical study titled "Multisystemic Therapy to Reduce Health Disparities in Adolescents With Asthma". Asthma is a chronic lung disease that inflames and narrows the airways. Symptoms can include recurring periods of wheezing, chest tightness, shortness of breath, and coughing. Minority, inner city teens are at increased risk for complications from the disease, possibly because of poor illness manage...
What is the current status of trial NCT00916240?
This trial is currently completed. It is a NA study. The enrollment target is 170 participants. The study started on 2008-09. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00916240?
The interventions under investigation include: Multisystemic Therapy (BEHAVIORAL), Home-based, Non-Directive Family Support (BEHAVIORAL).
Who is sponsoring clinical trial NCT00916240?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.